Stanford University
Showing 5,051-5,060 of 7,810 Results
-
Roger Noll
Professor of Economics, Emeritus
BioRoger G. Noll is professor of economics emeritus at Stanford University. Noll also is a Senior Fellow and member of the Advisory Board at the American Antitrust Institute. Noll received a B.S. with honors in mathematics from the California Institute of Technology and a Ph. D. in economics from Harvard University. Prior to joining Stanford, Noll was a Senior Economist at the President's Council of Economic Advisers, a Senior Fellow at the Brookings Institution, and Institute Professor of Social Science and Chair of the Division of Humanities and Social Sciences at the California Institute of Technology. At Stanford, Noll served as Associate Dean for Social Sciences in the School of Humanities and Sciences, Director of the Public Policy Program, and Senior Fellow in the Stanford Institute for Economic Policy Research where he also was Director of the Program in Regulatory Policy and Director of the Stanford Center for International Development.
Noll is the author or co-author of seventeen books and over three hundred articles and reviews. His primary research interests include technology policy; antitrust, regulation and privatization policies in both advanced and developing economies; economic aspects of public law (administrative law, judicial processes, and statutory interpretation); and the economics of sports and entertainment. Among Noll’s published books are Economic Aspects of Television Regulation (1973), Government and the Sports Business (1974), The Technology Pork Barrel (1991), Constitutional Reform in California (1995), Sports, Jobs and Taxes (1997), Challenges to Research Universities (1998), and Economic Reform in India (2013).
Noll has been a member of the advisory boards of the U.S. Department of Energy, Jet Propulsion Laboratory, National Aeronautics and Space Administration, National Renewable Energy Laboratory, and National Science Foundation. He also has been a member of the Commission on Behavioral and Social Sciences and the Board on Science, Technology and Economic Policy of the National Research Council, and of the California Council on Science and Technology.
Noll has been awarded a Guggenheim Fellowship, the annual book award of the National Association of Educational Broadcasters, the Rhodes Prize for undergraduate education at Stanford, the Distinguished Service Award of the Public Utilities Research Center, the Alfred E. Kahn Distinguished Career Award from the American Antitrust Institute, the Distinguished Member Award from the Transportation and Public Utilities Group of the American Economic Association, Economist of the Year from Global Competition Review, and the American Antitrust Institute award for Distinguished Achievement by an Economist in Antitrust Litigation. -
Douglas Noordsy
Clinical Professor, Psychiatry and Behavioral Sciences
BioDouglas L. Noordsy, MD, is Clinical Professor, Director of Lifestyle Psychiatry and co-founder of the Sports Psychology & Psychiatry clinic in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. Dr. Noordsy was previously Professor of Psychiatry at the Geisel School of Medicine at Dartmouth. His research interests include effects of physical exercise on neurotrophic factors, brain volume and function and mental health and wellbeing. He is particularly interested in the role of physical exercise for prevention of progression of early psychosis and interactions between social and physical aspects of team sports. Dr. Noordsy is a member of the American College of Psychiatry, American College of Lifestyle Medicine and is a Distinguished Fellow of the American Psychiatric Association. He is a member of the editorial boards for Community Mental Health Journal and Mental Health & Physical Activity. Dr. Noordsy was recognized with the Exemplary Psychiatrist Award from the National Alliance on Mental Illness in 2001, and the Excellence in Leadership Award from the Department of Psychiatry & Behavioral Sciences at Stanford in 2018. He launched the Stanford Lifestyle & Sports Psychiatry Special Initiative of the Department of Psychiatry in 2024 and is seeking philanthropic partners.
https://med.stanford.edu/psychiatry/special-initiatives/lifestyle.html
https://med.stanford.edu/psychiatry/patient_care/lifestyle.html -
Anthony Norcia
Professor (Research) of Psychology, Emeritus
Current Research and Scholarly InterestsVision, development, functional imaging, systems analysis
-
Kristin M. Nord, MD
Clinical Professor, Dermatology
BioKristin M. Nord, M.D., is a Clinical Professor of Dermatology and served as Residency Program Director from 2012-2022. Dr. Nord received her doctor of medicine from the Columbia University College of Physicians and Surgeons, and completed her residency in Dermatology at New York Presbyterian-Columbia University Medical Center. Dr. Nord is Attending Physician at the VA Palo Alto Health Care System, where her clinical interests are general dermatology, complex medical dermatology and procedural dermatology, and she serves as Assistant Co-Chief of Dermatologic Surgery. Her research focus is on skin cancer education and prevention, and she is co-faculty lead for SUNSPORT (Stanford University Sun Protection Outreach Research and Teamwork).
-
Robert L Norris Jr
Professor of Emergency Medicine at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsEnvironmental toxinology, with special emphasis on envenomations (particularly snake venom poisoning; Airway management techniques; Tactical medicine
-
Aimee Norton
Senior Research Scientist
BioAimee A. Norton is interested in the dynamics of the solar magnetic field and the dynamo process acting in the Sun and other stars. She is also active in researching flux emergence processes and MHD waves.
-
Jeffrey Norton, MD
Robert L. and Mary Ellenburg Professor of Surgery, Emeritus
Current Research and Scholarly InterestsInterleukin-12 is a Th1 cytokine. It is important in the cell mediated immune response. We are investigating its role as an anti-tumor cytokine to augment the immune response against cancer. We are planning a human trial.
